Natco Pharma surges 20%, hits new high on USFDA nod for cancer drug

The company has received approval from the US health regulator for the generic version of Celgene's multiple myeloma drug, Revlimid (Lenalidomide) capsules in the US

The company has received approval from the US health regulator for the generic version of Celgene's multiple myeloma drug, Revlimid (Lenalidomide) capsules in the US https://ift.tt/3unWP7H May 23, 2021 at 06:30PM

Comments

Popular posts from this blog

US may impose tariffs on India, Italy for taxing internet firms like Google

No locus standi: India rejects US global religious freedom report